Article
The Role of microRNAs in Multidrug Resistance of Glioblastoma
30 Jun 2022
Abstract excerpt
Glioblastoma (GBM) is an aggressive brain tumor that develops from neuroglial stem cells and represents a highly heterogeneous group of neoplasms. These tumors are predominantly correlated with a dismal prognosis and poor quality of life. In spite of major advances in developing novel and effective therapeutic strategies for patients with glioblastoma, multidrug resistance (MDR) is considered to be the major...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
